#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Porphyria non-acute Pemphigus Pleomorphic liposarcoma Breast cancer Metastatic gastric cancer Cholangitis sclerosing Haemolytic uraemic syndrome Marginal zone lymphoma recurrent Ewing's sarcoma metastatic Gestational trophoblastic tumour Adenoid cystic carcinoma Rhabdomyosarcoma Hereditary haemorrhagic telangiectasia Fibrodysplasia ossificans progressiva Retinal dystrophy More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Trials in Disease Turner’s syndrome – Life with Disease Crigler-Najjar syndrome Progressive multifocal leukoencephalopathy – Life with Disease Chondrosarcoma Medulloblastoma – Diagnostics Factor VIII deficiency – Diagnostics Primary biliary cholangitis – Life with Disease Leiomyosarcoma – Trials in Disease Cystic fibrosis lung – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vafidemstat [Al[18F]F]Fapi-74 Rbl007.2 Trastuzumab Emtansine Glycerol Lisaftoclax Ifosfamide Keto-Valine Calcium Valganciclovir Op-1250 Clonidine Hydrochloride Daplusiran Nystatin Doxylamine Hydrogen Succinate Amantadine Hydrochloride Urokinase Immunoglobulins, Normal Human Povetacicept Degarelix Acetate Etifoxine Hydrochloride More therapies…

    Learn about Your Condition

    Measles Hepatitis D Small cell lung cancer Pancreatic carcinoma stage IV Febrile neutropenia Uterine leiomyosarcoma Oropharyngeal cancer recurrent Pleomorphic leiomyosarcoma Testicular leiomyosarcoma Anaemia Torticollis Acute myeloid leukaemia Hypotransferrinaemia Dystonia Oxygen saturation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of ISIS 678354 for Patients with Familial Chylomicronemia Syndrome Previously Treated with Volanesorsen

    Recruiting

    3 1 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Sweden

  • Study on the Safety of Mitapivat for Adults with Red Blood Cell Membrane Disorders

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Red blood cell abnormality
    Investigated Drugs:
    • Mitapivat
    Denmark The Netherlands

  • Study of Fluoroestradiol F-18 and Biomarkers for Women with ER-Positive HER2-Negative Metastatic Breast Cancer After CDK4/6 Inhibitor Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Fluoroestradiol F-18
    France

  • Efficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy

    Recruiting

    3 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Givinostat
    Belgium Czechia France Germany Italy The Netherlands +3

  • Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren’s Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Deucravacitinib
    Austria Belgium Bulgaria Finland France Germany +9

  • Study on the Effects of Dobutamine on Heart Function in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Dobutamine
    • Sodium Chloride
    Denmark
Previous Page
1 … 556 557 558 559 560 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!